NCT01202253View on ClinicalTrials.gov

Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom

CompletedOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions

Candidiasis

Interventions

DRUG

anidulafungin

A single 200 mg loading dose should be administered on Day 1, followed by 100 mg daily thereafter.

Trial Locations (1)

SE5 9RS

Pfizer Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY